Abstract-The dopaminergic and renin-angiotensin systems regulate blood pressure, in part, by affecting sodium transport in renal proximal tubules (RPTs). We have reported that activation of a D 1 -like receptor decreases AT 1 receptor expression in the mouse kidney and in immortalized RPT cells from Wistar-Kyoto (WKY) rats. The current studies were designed to test the hypothesis that activation of the AT 1 receptor can also regulate the D 1 receptor in RPT cells, and this regulation is aberrant in spontaneously hypertensive rats (SHRs Key Words: dopamine Ⅲ kidney Ⅲ receptors, angiotensin II Ⅲ rats, spontaneously hypertensive A ngiotensin II and dopamine are important regulators of sodium and water transport across the renal proximal tubule (RPT). [1] [2] [3] [4] [5] [6] [7] [8] Angiotensin II receptor subtypes (AT 1 , AT 2 , and AT 4 ) are expressed in brush border and basolateral membranes of RPTs. [1] [2] [3] [4] [5] The activation of AT 1 receptors by low concentrations of angiotensin II (picomolar) causes an increase in sodium reabsorption in RPTs. 1, 3, 6 All the dopamine receptor subtypes, D 1 -like (D 1 and D 5 ) and D 2 -like (D 2 , D 3 , and D 4 ) are also expressed in brush border and basolateral membranes of RPTs. [7] [8] [9] [10] In contrast to the stimulatory effect of AT 1 receptors on renal sodium transport, activation of D 1 and D 3 receptors decreases renal sodium reabsorption. 7, 8, [11] [12] [13] Several reports have shown an interaction between the dopamine and renin-angiotensin system. Intrarenally produced angiotensin II opposes the natriuretic action of the D1-like dopamine receptor agonist, fenoldopam, in rats. 14 D 2 -like receptor agonists also antagonize the stimulatory effect of angiotensin II, acting via AT 1 receptors, on renal proximal tubular luminal sodium transport. 15, 16 When angiotensin II generation is inhibited or AT 1 receptors are blocked, the natriuretic effect of dopaminergic drugs is enhanced. 17 The AT 1 receptor mediates the anti-natriuretic effect of angiotensin II, whereas the D 1 dopamine receptor is responsible for Ϸ80% of D 1 -like receptor activity in RPTs. 18 We have reported that in RPT cells of Wistar-Kyoto (WKY) 
A ngiotensin II and dopamine are important regulators of sodium and water transport across the renal proximal tubule (RPT). [1] [2] [3] [4] [5] [6] [7] [8] Angiotensin II receptor subtypes (AT 1 , AT 2 , and AT 4 ) are expressed in brush border and basolateral membranes of RPTs. [1] [2] [3] [4] [5] The activation of AT 1 receptors by low concentrations of angiotensin II (picomolar) causes an increase in sodium reabsorption in RPTs. 1, 3, 6 All the dopamine receptor subtypes, D 1 -like (D 1 and D 5 ) and D 2 -like (D 2 , D 3 , and D 4 ) are also expressed in brush border and basolateral membranes of RPTs. [7] [8] [9] [10] In contrast to the stimulatory effect of AT 1 receptors on renal sodium transport, activation of D 1 and D 3 receptors decreases renal sodium reabsorption. 7, 8, [11] [12] [13] Several reports have shown an interaction between the dopamine and renin-angiotensin system. Intrarenally produced angiotensin II opposes the natriuretic action of the D1-like dopamine receptor agonist, fenoldopam, in rats. 14 D 2 -like receptor agonists also antagonize the stimulatory effect of angiotensin II, acting via AT 1 receptors, on renal proximal tubular luminal sodium transport. 15, 16 When angiotensin II generation is inhibited or AT 1 receptors are blocked, the natriuretic effect of dopaminergic drugs is enhanced. 17 The AT 1 receptor mediates the anti-natriuretic effect of angiotensin II, whereas the D 1 dopamine receptor is responsible for Ϸ80% of D 1 -like receptor activity in RPTs. 18 We have reported that in RPT cells of Wistar-Kyoto (WKY) rats, the D 1 -like agonist, fenoldopam, increased D 1 receptor but decreased AT 1 receptor protein expression. In contrast, in RPT cells of spontaneously hypertensive rats (SHRs), fenoldopam also decreased AT 1 receptor expression but no longer stimulated D 1 receptor expression. We also reported that AT 1 and D 1 receptors coimmunoprecipitate in RPT cells; fenoldopam increased this coimmunoprecipitation in WKY RPT cells but decreased it in SHR RPT cells. 19 We hypothesize that the AT 1 receptor may also regulate the D 1 receptor, including its expression. Therefore, we studied the effect of angiotensin II on D 1 receptor expression and AT 1 and D 1 receptor interaction in immortalized rat RPT cells. We have previously shown that the D 1 receptor effects on signal transduction and sodium transporters in immortalized RPT cells are similar to those obtained in freshly obtained renal proximal tubules. 20 -22 Parenti et al have also reported that the AT 1 receptor behaves similarly in freshly obtained renal tubules and immortalized RPT cells. 23 We now report that AT 1 and D 1 receptors colocalize in RPT cells. D 1 and AT 1 receptor coimmunoprecipitation was greater in WKY than in SHRs, in agreement with our previous report. 19 In this earlier study, long-term fenoldopam stimulation (24 hours) increased the coimmunoprecipitation of D 1 and AT 1 receptors in WKY but decreased it in SHRs. 19 We now show that angiotensin II decreases D 1 
Methods

Cell Culture
Immortalized RPT cells from 4-to 8-week-old WKY and SHRs were cultured at 37°C in 95% air/5% CO 2 atmosphere in DMEM/F-12 culture media, as previously described. [21] [22] [23] [24] [25] [26] The cells (80% confluence) were extracted in ice-cold lysis buffer (phosphate-buffered saline with 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L PMSF, 10 g/mL aprotinin, and 10 g/mL leupeptin), sonicated, kept on ice for 1 hour, and centrifuged at 16 000g for 30 minutes. The supernatants were stored at Ϫ70°C until use for immunoblotting and/or immunoprecipitation.
Immunoblotting
The antibodies are polyclonal purified antipeptides. The amino acid sequence for the immunogenic peptide (rabbit anti-human AT 1 receptor antibody) is QDDCPKAGRHC, amino acids 15 to 24 of the AT 1 receptor. The specificity of this antibody to the AT 1 receptor is indicated as previously reported. 27, 28 The amino acid sequence for rat D 1 receptor antibody corresponds to positions 299 to 307 (GSEETQPFC) on D 1 receptor (Research Genetics). The specificity of this D 1 receptor antibody has also been reported. 19, 29 Rat RPT cells were treated with vehicle (dH 2 O), angiotensin II or an AT 1 receptor antagonist (losartan) at the indicated concentrations and times. Immunoblotting was performed as previously reported, 22, 26 except that the transblots were probed with the D 1 (1:800) or the AT 1 receptor antibody (1:400). The amount of protein transferred onto the membranes was determined by Ponceau-S staining and immunoblotting for ␣-actin. 19 Immunofluorescence Confocal Microscopy of Double-Stained RPT Cells RPT cells, grown on coverslips, were fixed with 3% paraformaldehyde (30 minutes) and permeabilized with 0.1% Triton X-100 in phosphate-buffered saline (15 minutes). Reactions with antibodies were performed as described previously. 22, 30 The D 1 and AT 1 receptors were visualized by using a rabbit antipeptide polyclonal IgG affinity-purified rat D 1 receptor antibody followed by fluorescein isothiocyanate-conjugated anti-rabbit secondary antibody (Molecular Probes) or by a mouse anti-human AT 1 receptor monoclonal antibody followed by the secondary goat anti-mouse antibody labeled with Alexa 568 (Molecular Probes). 22 Cells on coverslips were mounted with the ProLong Antifade Kit (Molecular Probes). The immunofluorescence densities and images were acquired (Olympus AX70) at an excitation wavelength of 488 nm and 568 nm; emission was detected at 535 and 645 nm. 22, 30 Immunoprecipitation RPT cells were incubated with vehicle or angiotensin II (10 Ϫ8 M) for 24 hours, as described. The cells were lysed with ice-cold lysis buffer for 1 hour and centrifuged at 16 000g for 30 minutes. Equal amounts of lysates (500 g protein/mL supernatant for RPT cells from both SHR and WKY rats) were incubated with affinity-purified anti-D 1 receptor antibody (2 L/mL) for 1 hour and protein-G agarose at 4°C for 12 hours. The immunoprecipitates were pelleted and washed 4 times with lysis buffer. The pellets were suspended in sample buffer, boiled for 10 minutes, and subjected to immunoblotting with the AT 1 receptor antibody. To determine the specificity of the bands, preimmune serum of D 1 receptor antibody (negative control) and AT 1 receptor antibody (positive control) were used as immunoprecipitants, instead of the D 1 receptor antibody. The densities of the bands were quantified by densitometry using Quantiscan (Ferguson, Mo) as previously reported. 19, 22, 26 Cell Surface D 1 
Receptor Expression
Cultured RPT cells were starved in serum-free medium for 2 hours, and then treated with angiotensin II (10 Ϫ8 M) for 15 minutes. Surface membrane proteins were biotinylated by adding sulfo-NHS-LCbiotin (final concentration 250 g/mL) into the medium 5 minutes before adding angiotensin II. The cells were washed 3 times with wash buffer. Then, the cells were lysed with lysis buffer, sonicated and placed on ice for 1 hour. The supernatant from the cell lysate was immunoprecipitated with the anti-rat D 1 receptor antibody, followed by immunoblotting. The membrane sheets were blocked with 5% milk overnight and after washing (3 times), the sheets were incubated with peroxidase-conjugated streptavidin (Jackson ImmunoResearch Laboratory, Inc, in wash buffer at 1/5000 dilution for 30 minutes. The biotinylated protein bands were visualized by enhanced chemiluminescence (Western Blotting Detection Kit; Amersham, Arlington Heights, Ill). 31 
Materials
Rabbit anti-human AT 1 receptor antibodies were purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, Calif). Rabbit anti-rat D 1 receptor antibody was produced against a synthetic oligopeptide from the amino acid sequence of rat D 1 receptor (amino acids 299 to 307) (Research Genetics). Monoclonal mouse anti-human AT 1 receptor was purchased from Abcam Limited (Cambridge, UK). Angiotensin II was purchased from Peninsula Laboratory, Inc (St Louis, Mo). Losartan was a gift from Merck & Co (Philadelphia, Pa). Peroxidase-conjugated streptavidin was purchased from Jackson ImmunoResearch Laboratory, Inc (West Grove, Pa). Sulfo-NHS-LCbiotin was purchased from PIERCE (Rockford, Ill). Other chemicals for various buffers were of the highest purity available and purchased either from Sigma or Gibco.
Statistical Analysis
The data are expressed as meanϮSEM. Comparison within groups was made by ANOVA for repeated measures, and comparison among groups was made by factorial ANOVA with Duncan's test. PϽ0.05 was considered significant. To determine the specificity of angiotensin II action on AT 1 receptors, we studied the effect of the AT 1 receptor antagonist, losartan. Consistent with the results in WKY rats in Figure 1A , 1B, and 1C, angiotensin II (10 Ϫ8 M/24 hours) increased D 1 receptor expression (controlϭ0.83Ϯ0.15, angiotensin IIϭ1.48Ϯ0.15; nϭ8). The AT 1 receptor antagonist, losartan (10 Ϫ8 M), by itself, had no effect on D 1 receptor expression (0.8Ϯ0.13) but reversed the stimulatory effect of angiotensin II on D 1 receptor expression (0.7Ϯ0.08) ( Figure 1D ).
Results
Activation
To investigate whether there is a right-shift of the concentration-response curve in SHRs, their RPT cells were incubated with varying concentrations of angiotensin II (10 Ϫ9 M to 10 Ϫ5 M) for 24 hours. Consistent with the results in Figure 1C , angiotensin II had no effect on D 1 receptor expression in SHRs ( Figure 1E ).
AT 1 Receptor Colocalizes With the D 1 Receptor in Rat RPT Cells
Immunofluorescence laser confocal microscopy revealed a colocalization of D 1 and AT 1 receptors in WKY rat RPT cells (Figure 2 ). To determine whether there is a physical interaction between the D 1 and the AT 1 receptor, additional experiments were performed. As shown in Figure 3 , in the basal state, the band of 45 kDa, representing the coimmunoprecipitated D 1 and AT 1 receptors, was greater in RPT cells from WKY rats (37Ϯ1 DU) than in those from SHRs (23Ϯ3 DU, nϭ7, PϽ0.05), similar to the findings in our previous report. 19 
Activation of AT 1 Receptors Decreases the D 1 Receptor Expression in Surface Membranes of RPT Cells From WKY Rats But Not From SHRs
The effect of short-term stimulation with angiotensin II on cell surface D 1 receptors is shown in Figure 4 . Angiotensin II (10 Ϫ8 M) decreased the quantity of D 1 receptors on the cell surface membranes in WKY RPT cells, but not in SHR RPT cells (WKY: controlϭ45Ϯ9 DU, angiotensin IIϭ17Ϯ5 DU; SHR: controlϭ19Ϯ3 DU, angiotensin IIϭ19Ϯ5 DU, nϭ6).
Discussion
Polygenic essential hypertension is associated with increased sodium transport in renal proximal tubules. 32, 33 As mentioned, dopamine and angiotensin II are important regulators of sodium and water reabsorption in the kidney, serving contrasting functions in the proximal tubule. 1, 5, 17, 34, 35 Both dopamine and renin-angiotensin systems exist in the RPT, and the components of the renin-angiotensin system, including angiotensinogen mRNA, renin, and angiotensinconverting enzyme, have been localized to the proximal tubule. 1, 6, 36, 37 The proximal tubule is also the site of local dopamine production. 38 -40 Urinary dopamine and angiotensin II concentrations exceed circulating levels, suggesting both systems may have autocrine and/or paracrine effects in RPTs. 1, 6, 38, 41 Angiotensin II stimulates sodium reabsorption via activation of sodium transporting proteins that are inhibited by dopamine (NHE3, Cl/HCO 3 exchanger, Na/HCO 3 cotransporter, and Na ϩ /K ϩ ATPase). 34, 35 Dopamine and D 1 -like and D 2 -like receptor agonists have been reported to antagonize the actions of angiotensin II on NHE3 and Na ϩ K ϩ -ATPase activities in brush border and basolateral membranes of renal proximal tubules. 15, 16 Dopamine, via D 1 -like receptors, has also been reported to decrease the AT 1 receptor mRNA and protein, as well as angiotensin II binding sites in renal proximal tubules. 19, 42 The effect of angiotensin II on D 1 -like receptors has not been reported.
In WKY RPT cells, stimulation of the AT 1 receptor with angiotensin II for 2 different periods (short-term or longterm) yields opposite results; short-term stimulation decreases cell surface D 1 receptor expression, whereas longterm stimulation increases whole cell D 1 receptor expression. It is unlikely that the change in the short-term could account for the long-term result. A decrease of cell surface D 1 receptor expression would remove a restraint allowing AT 1 receptor activation to increase sodium reabsorption to a greater extent. However, the increase in D 1 receptor expression would tend to counterbalance the prolonged angiotensin II effect.
Cell surface membrane localization of G protein-coupled receptors is decreased by phosphorylation of the receptor. 8, 43 We have reported that G protein-coupled receptor kinases (GRKs), GRK2 and GRK4, are involved in D 1 receptor phosphorylation. 44 Among the GRKs, GRK2 is most impor- tant in promoting AT 1 receptor phosphorylation. 45 It is possible that the GRK2 activation subsequent to AT 1 receptor stimulation also results in the alteration of the phosphorylation and membrane localization of the D 1 receptor. Such a scenario can explain the ability of AT 1 receptors to decrease the membrane localization of the D 1 receptor in WKY. This does not occur in SHRs because the D 1 receptor is already hyperphosphorylated and fewer D 1 receptors are found on renal cell surface membranes in SHR. 46 Although GRK4 is the major GRK regulating D 1 receptor function, 43, 44 GRK4 is not involved in the desensitization of the AT 1 receptor. 47 The possibility exists that the AT 1 receptor can cause heterologous desensitization of the D 1 receptor via stimulation of effector enzymes, but it is not clear which one. 48 The dephosphorylation of D 1 receptors in renal proximal tubules is also different in WKY and SHRs. We have reported that short-term D 1 -like receptor stimulation increases protein phosphatase 2A activity in renal proximal tubules in WKY but not in SHRs 49 . It is possible that in the WKY, the AT 1 receptor inhibits protein phosphatase 2A activity and thus prevents dephosphorylation and recycling of the D 1 receptor to the cell surface membrane. Although there is no report to support this mechanism, AT 2 receptor has been reported to stimulate protein phosphatase 2A activity. 50, 51 Long-term stimulation of AT 1 receptors increases total cellular D 1 receptor expression in WKY. This finding in vitro was also found in vivo; chronic angiotensin II infusion in mice also caused an increase in D 1 receptor expression (unpublished data). Presumably, cell surface D 1 receptor expression is also increased. Although the mechanism by which AT 1 receptor stimulation increases D 1 receptor expression remains to be determined, such an effect could serve as a physiological negative feedback under normal circumstances (in WKY). However, in SHR cells, this upregulation of D 1 receptors by stimulation of AT 1 receptors is lost because of decreased responsiveness of the hyperphosphorylated D 1 receptor. 46, 52, 53 We have reported that the renal D 1 receptor is hyperphosphorylated in SHRs as a consequence of increased activity of GRK4 54 and decreased protein phosphatase 2A activity. 49 Long-term incubation with angiotensin II decreases D 1 /AT 1 receptor coimmunoprecipitation to the same degree in cells from SHR and WKY rats. Our previous study showed that long-term exposure to angiotensin II decreases AT 1 receptor protein expression in RPT cells from WKY rats but increases it in SHRs. 26 The decreased interaction between D 1 and AT 1 receptors in renal proximal tubules in WKY rats is, therefore, not the result of decreased AT 1 receptor expression, per se, because a similar response is seen in SHRs where AT 1 expression is increased by angiotensin II. Thus, angiotensin II, via the AT 1 receptor, probably causes a decrease in the physical interaction of AT 1 and D 1 receptors in both WKY and SHR cells. Further studies are needed to determine whether the decreased interaction between these 2 receptors is direct or indirect, possibly by the alteration of an adaptor gene or adaptor proteins.
In both SHR and Dahl salt-sensitive rats, dopamine and D 1 -like receptor agonist-mediated natriuretic and diuretic responses are impaired. 8, 43 The impaired D 1 -like receptor function in hypertension is not caused by abnormalities in G proteins, effectors, or ion transporting proteins, such as adenylyl cyclase, NHE3 or Na ϩ -K ϩ ATPase. Rather, the renal D 1 -like receptor is uncoupled from G protein subunits, leading to decreased D 1 -like receptor interaction with G protein subunits, and resulting in decreased production of second messengers and decreased interaction between G protein subunits, effector enzymes, and ion transporters. 8, 43, 53 To determine whether the impaired D 1 receptor function occurs at the receptor level, we investigated the expression of D 1 receptor expression in cell surface membranes and whole cells. We found that cell surface membrane expression of D 1 receptors is lower and D 1 receptor phosphorylation is higher in SHR cells than in WKY cells, although total and D 1 receptor expression are not different in the 2 cell lines. 46, 54 Renal D 1 receptor phosphorylation and GRK4 activity impact on the regulation of blood pressure. Inhibition of renal GRK4 activity by antisense oligonucleotides attenuates the increase in blood pressure with age in SHRs without affecting blood pressure in WKY rats. 55 In summary, we have demonstrated that long-term stimulation of AT 1 
Perspectives
The dopaminergic and renin-angiotensin system are 2 important systems that regulate blood pressure. [1] [2] [3] [4] [5] [6] [7] [8] Dopamine promotes natriuresis, whereas angiotensin II decreases sodium excretion. [1] [2] [3] [4] [5] [6] [7] [8] The major D 1 -like receptor subtype mediating the increase in sodium excretion is probably the D 1 receptor, whereas the major angiotensin II receptor mediating the decrease in renal sodium excretion is the AT 1 receptor. [1] [2] [3] [4] [5] [6] [7] [8] In SHRs, renal proximal tubular D 1 receptor function is impaired. 7, 8 Regardless of the mechanism involved in the interaction between D 1 and AT 1 receptors, the dissociation of D 1 from AT 1 receptors after angiotensin II stimulation may allow the AT 1 and D 1 receptor to exert their functions separately. Renal proximal tubular D 1 receptors are functional in WKY but not in SHRs. In contrast, AT 1 receptor function is enhanced in SHRs. 32 The inability of AT 1 receptors to increase D 1 receptor expression in renal proximal tubules in SHRs and a decreased D 1 and AT 1 receptor interaction could lead to enhanced AT 1 receptor function.
